FHFatemeh Homayounifar

Fatemeh Homayounifar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fatemeh Homayounifar has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Ali Amanati

    Clinical Research Development Center, Amir Oncology Teaching Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

    1 shared publication
  • Armina Farkarian

    Clinical Research Development Center, Amir Oncology Teaching Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

    1 shared publication
  • Elahe Meftah

    Clinical Research Development Center, Amir Oncology Teaching Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

    1 shared publication
  • Fatemeh Noushadi

    Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

    1 shared publication
  • Ghazal Davar

    Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

    1 shared publication
  • Hassan Joulaei

    Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

    1 shared publication

Latest Publications

  • Open Access

    Implications Derived from Global Experiences of Barriers to Integrating Community Pharmacists into Primary Healthcare: A Scoping Review

    by Fatemeh Homayounifar, Mohsen Khosravi, Ghazal Davar, Manica Negahdaripour, Hassan Joulaei

    Introduction/objectives: Primary healthcare (PHC) is a comprehensive and efficient system that promotes people’s health by providing a range of services in easily accessible locations. Integrating pharmacists into PHC has emerged as a promising approach to enhance healthcare delivery. This study aimed to explore the barriers to integrating community pharmacists into the various components of PHC. Methods: A scoping review was conducted in 2024 reviewing the evidence published between 2000 and 2024. For such purpose, multiple databases were searched including PubMed, Scopus, ProQuest, Web of Science, and the Google Scholar. Results: A total of 90 studies were found to be eligible for inclusion. The study identified key challenges to pharmacists’ integration in PHC across 6 areas: governance issues such as lack of trust and regulatory barriers; financial constraints and payment problems; workforce shortages and inadequate training; infrastructure and technology limitations; restricted access to health information; and service delivery problems including poor collaboration and fragmented care. Conclusions: The study provided several barriers to pharmacists integration in PHC. In such context, the study proposed policymakers to fund sustainably, strengthen infrastructure, enact supportive policies, and promote collaboration, coordination, and expanded pharmacist roles.


  • Open Access

    Prevalence, microbiology, and antimicrobial susceptibility profile of bacterial skin and soft tissue infections in pediatric patients with malignancies at a referral teaching hospital in Shiraz, Iran

    by Seyed Reza Abdipour Mehrian, Fatemeh Noushadi, Yaser Pourasghar, Armina Farkarian, Elahe Meftah, Fatemeh Homayounifar, Ali Amanati

    Skin and soft tissue infections (SSTIs) in pediatric oncology patients present significant challenges owing to their immunocompromised condition and susceptibility to severe infections. This study aimed to assess the prevalence, microbiology, and antibiotic resistance patterns of SSTIs in children with malignancies admitted to a referral teaching hospital. A total of 227 pediatric patients with cancer were included in this descriptive cross-sectional study. The data collected included demographics, malignancy type, neutropenic status, infection sites, microbial culture results, and clinical outcomes. Bacterial cultures were performed on samples from the blood, wounds, and other infection-related sites. Pathogens were identified using standard microbiological methods, and antibiotic susceptibility was determined using the disk diffusion (Kirby-Bauer) method, following the Clinical and Laboratory Standards Institute (CLSI) guidelines. Among the 227 patients, 57.71% were male and 42.29% were female, and the most prevalent age group was 1 to 6 years (39.65%). Hematologic malignancies were observed in 57.33% of the patients, solid tumors in 39.11%, and leukemia was the most common malignancy (40.81%). Bloodstream infections (BSIs) were identified in 7.05% of patients, while a notable proportion of cases (92.95%) were culture-negative, warranting consideration of non-bacterial etiologies or prior antibiotic use. Among the 227 site-specific culture samples, Escherichia coli (36.54%) and Staphylococcus aureus (23.08%) were the most common pathogens. Other frequently isolated bacteria include Pseudomonas aeruginosa, Klebsiella spp., and coagulase-negative Staphylococcus. Antibiotic sensitivity testing revealed that E. coli is sensitive to ampicillin-sulbactam and colistin, whereas S. aureus is sensitive to chloramphenicol and cotrimoxazole. In terms of patient outcomes, > 95% of patients achieved complete recovery, whereas 3.96% had fatal outcomes. Multivariate analysis identified age < 5 years (adjusted odds ratio [aOR] = 8.03, p = 0.004) and perianal abscesses (aOR = 4.4, p = 0.038) as independent risk factors significantly associated with an increased risk of BSI. Male sex was associated with a reduced risk for BSI (aOR = 0.62). Our study highlights the significant burden of SSTIs in pediatric oncology patients, with E. coli and S. aureus being the predominant pathogens. Younger age and perianal abscesses were identified as independent risk factors of BSI, emphasizing the need for heightened vigilance in these subgroups. These findings underscore the importance of targeted preventive strategies to improve the outcomes in this high-risk population. However, it is important to acknowledge that this study was conducted at a single center and the high rate of culture-negative results suggests that non-bacterial etiologies or prior antibiotic use may play a significant role. Not applicable.